Preparations, characterizations and applications of Chitosan-based nanoparticles

Journal of Ocean University of China

Volumn 6, Issue 3, 2007, Pages 237-243

  Liu, Chenguang ^a   Tan, Yulong ^a   Liu, Chengsheng ^a   Chen, Xiguang ^a   Yu, Lejun ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

Author keywords

Chitosan; Delivery system; Nanoparticle

Indexed keywords

EID: 34547586281     PISSN: 16725182     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11802-007-0237-9     Document Type: Review

References (47)

1. Chen, X. G., C. M. Lee, and H. J. Park, 2003. O/W emulsification for the self-aggregation and nanoparticle formation of linoleic acids modified chitosan in the aqueous system. J. Agric. Food Chem., 51: 3135-3139.
2. Christopher, P. L., and S. L. Philip., 2001. Folate-mediated targeting: from diagnostics to drug and gene delivery. Drug Discov. Today, 6: 44-51.
3. Corsi, K., F. Chellat, L. Yahia, and J. C. Fernandes, 2003. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials, 24: 1255-1264.
4. Cui, Z., and R. J. Mumper, 2001. Chitosan-based nanoparticles for topical genetic immunization. J. Control. Release, 75: 409-419.
5. Dyer, A. M., M. Hinchcliffe, P. Watts, J. Castile, I. Jabbal-Gill, et al., 2002. Nasal delivery of insulin using novel chitosan based formulations: A comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. Pharma. Res., 19: 998-1008.
6. Erbacher, P., S. Zou, T. Bettinger, A. M. Steffan, and J. S. Remy, 1998. Chitosan-based vector/DNA complexes for gene delivery: Biophysical characteristics and transfection ability. Pharma. Res., 159: 1332-1339.
7. Felt, O., P. Buri, and R. Gurny, 1998. Chitosan: A unique polysaccharide for drug delivery. Drug Devel. Indus. Pharm., 24: 979-993.
8. Fernandez-Urrusuno, R., P. Cavlo, C. Remunan-Lopez, J. L. Vila-Jato, and M. J. Alonso, 1999. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm. Res., 16: 1576-1581.
9. Gao, S., J. Chen, X. Xu, Z. Ding, Y.H. Yang, et al., 2003. Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting. Int. J. Clin. Pharm. Res., 255: 57-68.
10. Illum, L., I. Jabbal-Gill, M. Hinchcliffe, A. N. Fisher, and S. S. Davis, 2001. Chitosan as a novel nasal delivery system for vaccines. Adv. Drug Deliv. Rev., 51: 81-96.
11. Janes, K. A., P. Calvo, and M. J. Alonso, 2001a. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug Deliv. Rev., 47: 83-97.
12. Janes, K. A., M. P. Fresneau, M. Ana, F. Angels, and J. A. Maria, 2001b. Chitosan nanoparticles as delivery systems for doxorubicin. J. Control. Release, 73: 255-267.
13. Jong, H. K., S. K. Yoo, K. W. Sung, J. H. Park, K. Kim, et al., 2006. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. J. Control. Release, 111: 228-234.
14. Kataoka, K., T. Matsumoto, M. Tokohama, T. Okano, Y. Sakurai, et al., 2000. Doxorubicin-loaded poly(ethylene glycol)-poly(b-benzyl-L-aspartate) copolymer micelles: Their pharmaceutical characteristics and biological significance. J. Control. Release, 64: 143-153.
15. Kim, T. H., I. K. Park, J. W. Nah, Y. J. Choi and C. S. Cho, 2004. Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier. Biomaterials, 25: 3 783-3 792.
16. Lee, K. Y., J. H. Kim, I. C. Kwon, and S. Y. Jeong, 2001. Self-aggregates of deoxycholic acid-modified chitosan as a novel carrier of adriamycin. Coll. Polym. Sci., 278: 1216-1219.
17. Liu, C. G., K. G. H. Desai, X. G. Chen, and H. J. Park, 2005a. Linolenic Acid-Modified Chitosan for Formation of Self-Assembled Nanoparticles. J. Agric. Food Chem., 53: 437-441.
18. Liu, C. G., X. G. Chen, and H. J. Park, 2005b. Self-assembled nanoparticles based on linoleic-acid modified chitosan: Stability and adsorption of trypsin. Carbohyd. Polym., 62: 293-298.
19. MacLaughlin, F. C., R. J. Mumper, J. Wang, J. M. Tagliaferri, I. Gill, et al., 1998. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J. Control. Release, 56: 259-272.
20. Mao, H. Q., K. Roy, V. L. Troung-Le, K. Y. Lim, Y. Wang, et al., 1997. DNA-chitosan nanospheres: Derivitization and storage stability. P. Int. Symp. Control. Release. Bioact. Mater., 24: 671-672.
21. Mao, H. Q., K. Roy, V. L. Troung-Le, K. A. Janes, K. Y. Lim, et al., 2001. Chitosan DNA nanoparticles as gene delivery carriers: Synthesis, characterization and transfection efficiency. J. Control. Release, 70: 399-421.
22. Mitra, S., U. Gaur, P. C. Ghosh, and A. N. Maitra, 2001. Tumor targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J. Control. Release, 74: 317-323.
23. Murata, J., Y. Ohya and T. Ouchi, 1996. Possibility of application of quaternary chitosan having pendant galactose residues as gene delivery tool. Carbohyd. Polym., 29: 69-74.
24. Ohya, Y., M. Shiratani, H. Kobayashi, and T. Ouchi, 1994. Release behavior of 5-fluorouracil from chitosan-gel nanospheres immobilizing 5-fluorouracil coated with polysaccharides and their cell specific cytotoxicity. Pure Appl. Chem., A31: 629-642.
25. Park, I. K., T. H. Kim, Y. H. Park, B. A. Shin, E. S. Choi, et al., 2001. Galactosylated chitosan-graft-poly (ethylene glycol) as hepatocyte-targeting DNA carrier. J. Control. Release, 76: 349-362.
26. Park, J. H., S. Kwon, M. Lee, H. Chung, H. K. Ji, et al., 2006, Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: In vivo biodistribution and anti-tumor activity. Biomaterials, 27: 119-126.
27. Richardson, S. C. W., H. V. J. Kolbe, and R. Dunean, 1999. Potential of low molecular mass chitosan as a DNA delivery system: Biocompatibility, body distribution and ability to complex and protect DNA. Int. J. Pharm., 178: 231-243.
28. Roy, K., H. Q. Mao, and K. W. Leong, 1997. DNA-chitosan nanosperes: transfection effiency and cellar uptake. Preoceeding Int. Symp. Control. Release. Bioact. Mater., 24: 673-674.
29. Sania, M., C. Yan, W. Francoise, S. Qin, L. Patrick, et al., 2006. Characterization of folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials, 27: 2060-2065.
30. Sato, T., T. Ishii and Y. Okahata, 2001. In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials, 22: 2075-2080.
31. Se, K. K., and R. Niranjan, 2005. Enzymatic production and biological activities of chitosan oligosaccharides (COS): A review. Carbohyd. Polym., 62: 357-368.
32. Sevda, S., and S. J. McClureb, 2004. Potential applications of chitosan in veterinary medicine. Adv. Drug Deliver. Rev., 56: 1467-1480.
33. Son, Y. J., J. S. Jang, Y. W. Cho, H. Chung, R. W. Park, et al., 2003. Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. J. Control. Release, 91: 135-145.
34. Sunil, A. A., N. M. Nadagouda, and M. Tejraj, 2004. Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J. Control. Release, 100: 5-28.
35. Takeuchi, H., H. Yamamoto, and Y. Kawashima, 2001. Mucoadhesive nanoparticle systems for peptide drug delivery. Adv. Drug Deliver. Rev., 47: 39-54.
36. Thanou, M., B. I. Florea, M. Geldof, H. E. Junginger and G Borchard, 2002. Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines. Biomaterials, 23: 153-159.
37. Tokumitsu, H., H. Ichikawa, and Y. Fukumori, 1999. Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron capture therapy of cancer: Preparation by novel emulsiondroplet coalescence technique and characterization. Pharm. Res., 16: 1830-1835.
38. Uchegbu, I. F., A. G. Schatzlein, L. Tetley, A. I. Gray, J. Sludden, et al., 1998. Polymeric chitosan-based vesicles for drug delivery. J. Pharm. Pharmacol., 50: 453-458.
39. Van der Lubben, I. M., J. C. Verhoef, G. Borchard, and H. E. Junginger, 2001. Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur. J. Pharm. Sci., 14: 201-207.
40. Van der Lubben, I. M., J. C. Verhoef, G. Borchard, and H. E. Junginger, 2001. Chitosan for mucosal vaccination. Adv. Drug Deliver. Rev., 52: 139-144.
41. Vila, A., A. Sa-nchez, K. Janes, I. Behrens, T. Kissel, et al., 2004. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur. J. Pharm. Biopharm., 57: 123-131.
42. Wang, S., J. Luo, D. A. Lantrip, D. J. Waters, C. J. Mathias, et al., 1997. Design and synthesis of DTPA-folate for use as a tumortargeted radiopharmaceutical. Bioconjugate Chem., 8: 673-679.
43. Xu, Y. M., Y. M. Du, R. H. Huang, and L. P. Gao, 2003. Preparation and modification of N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a protein carrier. Biomaterials, 24: 5015-5022.
44. Yokohama, M., S. Fukushima, R. Uehara, K. Okamoto, K. Kataoka, et al., 1998. Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor. J. Control. Release, 50: 79-92.
45. Yoo, H. S., and T. G. Park, 2004a. Folate receptor targeted biodegradable polymeric doxorubicin micelles. J. Control. Release, 96: 273-283.
46. Yoo, H. S., and T. G. Park, 2004b. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J. Control. Release, 100: 247-256.
47. Yoo, H. S., J. E. Lee, H. Chung, I. C. Kwon, and S. Y. Jeong, 2005. Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery. J. Control. Release, 103: 235-243.